Abstract-Short-term blood pressure (BP) variability predicts cardiovascular complications in hypertension, but its association with large-artery stiffness is poorly understood and confounded by methodologic issues related to the assessment of BP variations over 24 hours. Carotid-femoral pulse wave velocity (cfPWV) and 24-hour ambulatory BP were measured in 911 untreated, nondiabetic patients with uncomplicated hypertension (learning population) and in 2089 mostly treated hypertensive patients (83% treated, 25% diabetics; test population). Short-term systolic BP (SBP) variability was calculated as the following: (1) SD of 24-hour, daytime, or nighttime SBP; (2) weighted SD of 24-hour SBP; and (3) average real variability (ARV), that is, the average of the absolute differences between consecutive SBP measurements over 24 hours. In the learning population, all of the measures of SBP variability showed a direct correlation with cfPWV (SD of 24-hour, daytime, and nighttime SBP, rϭ0.17/0.19/0.13; rϭ0.21; ARV, rϭ0.26; all PϽ0.001). The relationship between cfPWV and ARV was stronger than that with 24-hour, daytime, or nighttime SBP (all PϽ0.05) and similar to that with weighted SD of 24-hour SBP. In the test population, ARV and weighted SD of 24-hour SBP had stronger relationships with cfPWV than SD of 24-hour, daytime, or nighttime SBP. In both populations, SBP variability indices independently predicted cfPWV along with age, 24-hour SBP, and other factors. We conclude that short-term variability of 24-hour SBP shows an independent, although moderate, relation to aortic stiffness in hypertension. This relationship is stronger with measures of BP variability focusing on short-term changes, such as ARV and weighted 24-hour SD. (Hypertension. 2012; 60:369-377.) • Online Data Supplement Key Words: blood pressure Ⅲ pulse wave velocity Ⅲ arterial stiffness Ⅲ blood pressure variability Ⅲ average real variability A lthough the adverse cardiovascular consequences of high blood pressure (BP) are believed to depend primarily on the increased average BP levels, the degree of BP variability (BPV) has been more recently shown to represent an additional correlate and possibly a causal factor of the hypertension-related cardiovascular complications. Shortterm BPV within a 24-hour period is increasingly recognized as both a marker and a risk factor for cardiovascular disease.
A lthough the adverse cardiovascular consequences of high blood pressure (BP) are believed to depend primarily on the increased average BP levels, the degree of BP variability (BPV) has been more recently shown to represent an additional correlate and possibly a causal factor of the hypertension-related cardiovascular complications. Shortterm BPV within a 24-hour period is increasingly recognized as both a marker and a risk factor for cardiovascular disease. [1] [2] [3] [4] [5] [6] [7] [8] Short-term BPV reflects sympathetic nerve activation, 9 impaired baroreflex sensitivity, 10, 11 and other intrinsic and environmental factors. 12 The clinical assessment of short-term BPV has been, in most instances, based on calculation of the SD of 24-hour average BP values, obtained through noninvasive intermittent 24-hour ambulatory BP monitoring (ABPM). However, several important methodologic drawbacks of such an approach have been reported. These are related either to the low-frequency discontinuous sampling of BP variations occurring over 24 hours 13, 14 or to the inclusion in the calculation of 24-hour BP SD 4, 15 of the BP changes between day and night, that is, of a component of 24-hour BP variance carrying favorable prognostic implications. 4, [16] [17] [18] To overcome some of these limitations, other parameters quantifying short-term BPV have been more recently proposed, including the calculation of the "residual BPV" remaining after exclusion of the slower components of the 24-hour BP profile through spectral analysis 4, 19 ; the average of daytime and nighttime BP SD, each weighted for the duration of the day and night periods, respectively ("weighted" 24-hour BP SD) 15 ; and the average of the absolute differences between consecutive measurements ("average real variability"). 20 These newer parameters have been suggested to be better predictors of organ damage and cardiovascular risk than the conventional 24-hour SD. 15, 20, 21 Carotid-to-femoral pulse-wave velocity (cfPWV) is considered the gold standard for the noninvasive measurement of large-artery stiffness and is increasingly recognized as an independent predictor of cardiovascular morbidity and mortality, both in the general population [22] [23] [24] and in high-risk conditions, including hypertension, 25 end-stage renal disease, 26 and type 2 diabetes mellitus. 27 Animal studies have clearly shown that an increased short-term BPV might induce atherosclerotic lesions in the arterial wall, 28 leading to a reduced arterial distensibility. 29, 30 On the other hand, data are available in hypertensive humans that an increased systolic BPV is associated with arterial wall alterations, such as an increased intima media thickness of the carotid arteries, 31 although the cross-sectional nature of the available observations does not allow us to assess whether arterial wall alterations are the cause or the consequence of an increased BPV.
The present study was undertaken to explore the relation between short-term BPV and arterial stiffness in human hypertension. This was done by examining 2 large populations of hypertensive patients who underwent office BP measurements and automated 24-hour ABPM under standardized conditions and in whom aortic stiffness was measured noninvasively through cfPWV. The relation between cfPWV and the degree of short-term BP fluctuations was explored by considering different measures of BPV.
Methods
This article reports on data collected in 2 separate populations, a "learning population" of untreated hypertensive patients and a "test population" of both treated and untreated hypertensives. The latter data set was analyzed with the aim of confirming the findings obtained in the learning population.
Learning Population
The learning population consisted of 911 individuals coming from 2 populations of untreated mild-to-moderate hypertensive patients. One population included 639 subjects with essential hypertension consecutively referred to the hypertension outpatient clinic of the Department of Clinical and Experimental Medicine of the University of Perugia by their general practitioners for baseline off-treatment evaluation between January 2005 and December 2011 ("Perugia group"). The second population consisted of 272 untreated hypertensive patients participating in a clinical trial comparing combination therapies with an angiotensin-converting enzyme inhibitor and a calcium antagonist with the individual components (Institut De Recherches Internationales Servier, Courbevoie, France, Study CL2-05985-005). Patients were recruited in hypertension centers in France, Russia, Ukraine, Latvia, Lithuania, and Hungary between January and December 2008. For the present analysis, the baseline data, obtained at the end of the 3 week placebo run-in period, were used ("IRIS group"). Subjects with office SBP between 150 and 179 mm Hg and office diastolic BP (DBP) between 95 and 109 mm Hg were included.
In both of these groups, all of the subjects underwent clinical examination, 24-hour ABPM, and measurement of cfPWV. Exclusion criteria of Perugia population were as follows: clinical or laboratory evidence of heart failure, coronary artery disease, cerebrovascular disease, secondary causes of hypertension, serum creatinine Ն124 mol/L in men and Ն106 mol/L in women, major noncardiovascular disease, known diabetes mellitus or fasting plasma glucose Ն7.0 mmol/L, and treatment with any cardiovascular drugs, including nitrates. Exclusion criteria for the IRIS population were similar and included associated major clinical conditions (cerebrovascular, heart, renal, peripheral vascular diseases, or advanced retinopathy), diabetes mellitus, left ventricular hypertrophy, and microalbuminuria.
In addition, patients were excluded if they had the following: rhythm disorders leading to wide beat-to-beat BP variations, predictable difficulties for the patient to tolerate the ABPM device, and predictable difficulties to perform correct ABPM (including anatomic abnormalities of the arm and patients with an arm circumference Ͼ42 cm). Patients working at night and shift workers were also excluded to avoid interference with 24-hour BPV analysis. Written informed consent was obtained from each subject, and the study protocols were reviewed and approved by the institutional ethics committees.
Office and Ambulatory BP Measurement
In both groups, office BP was measured by a physician in the hospital outpatient clinic with a mercury sphygmomanometer (Perugia group), or with a validated oscillometric device (Microlife BP3AC1-1, IRIS group) with the subject sitting for Ն10 minutes. The average of 3 measurements was considered for the analysis.
Ambulatory BP in both groups of patients was recorded using a validated oscillometric device (SpaceLabs model 90207, SpaceLabs Inc, Redmond, WA), set to take a reading every 15 minutes throughout the 24 hours. The nocturnal interval of 15 minutes between 2 consecutive readings was chosen because it represents a requirement for proper assessment of BPV, 13 whereas at the same time it does not alter significantly sleep quantity, nocturnal BP, and its correlation with target organ damage. 32 Normal daily activities were allowed and encouraged, and patients were told to keep their cuff arm (nondominant arm was selected) still and relaxed to the side during measurements. The daytime period was defined as the time interval between 10:00 AM and 8:00 PM and the nighttime period as that between 12:00 AM and 6:00 AM, according to the narrow fixed-time intervals approach to exclude from analysis the hours of transition between wakefulness and sleep, different in different subjects. 33 Reading, editing, and analysis of data were done as described previously. 34 Only recordings fulfilling predefined quality criteria (Ն80% of expected valid readings available, no consecutive hours without valid readings, and Յ3 hours without valid readings) were considered for analysis. In the IRIS population, all of the readings were individually validated by the ABPM core center (Istituto Auxologico Italiano, Milan, Italy).
Definitions of Short-Term BPV
Because the SD of the mean of all of the individual BP values obtained over the 24 hours not only reflects short-lasting BP changes but is also strongly influenced by the amount of day-night BP changes, 15 additional and more specific indices of short-term BPV, able to avoid the contribution to overall variance given by the nocturnal fall of BP, were computed, namely: (1) the SD of daytime (systolic and diastolic) BP (day-SD); (2) the SD of nighttime (systolic and diastolic) BP (night-SD); (3) weighted 24-hour BP SD, defined as the mean of daytime and nighttime (systolic or diastolic) BP SD weighted by the duration (in number of hours) of each time period (wSD) 15 ; and (4) average real variability of 24-hour (systolic or diastolic) BP, calculated using the following formula (ARV) 20 :
where N denotes the number of valid BP measurements in the ABPM data corresponding with a given subject.
Measurement of Pulse Wave Velocity
For the learning population, cfPWV was determined noninvasively with the commercially available SphygmoCor system (SphygmoCor Vx, AtCor Medical, Sydney, New South Wales, Australia), which uses a high-fidelity applanation tonometer to measure the pressure pulse waveforms sequentially in 2 peripheral artery sites. cfPWV was obtained from measurements of common carotid and femoral artery waveforms, as described previously. 35 Transit time was calculated using R-wave on the surface ECG as a common reference. cfPWV was automatically calculated from measurements of pulse transit time and distance between the 2 sites, according to the following formula: cfPWV (m/s)ϭdistance (m)/transit time (s). In the Perugia group, the path length was calculated by subtracting the distance between the carotid artery measurement site and suprasternal notch, from the distance between the femoral artery site and the suprasternal notch, all measured directly with a caliper. In the IRIS group, the path was calculated as 0.8 times the straight distance between the carotid and femoral site. 36 The 2 measures have been found to be equivalent in a large database. 36 In the Perugia laboratory, the intraobserver coefficient of variation of cfPWV in 50 subjects was 5.1%, 37 and a similar figure characterizes the intraobserver reproducibility in the Paris arterial tonometry core center in charge of the multicenter cfPWV assessment in the IRIS group. 38 In the latter group, all of the investigators underwent a dedicated training session, and all of the tonometric recordings were validated by an arterial tonometry core center (Hôpital Européen Georges Pompidou, Paris, France).
Serum cholesterol, glucose, and creatinine concentrations were determined using standard techniques. Glomerular filtration rate was estimated through the use of the abbreviated Modification of Diet in Renal Disease equation. 39 All of the determinations were made between 8:00 AM and 10:00 AM in a room with controlled temperature after overnight fast.
Test Population
With the aim of replicating the findings of the learning population and of confirming their validity, we included another completely independent population of 2089 subjects consecutively referred to the hypertension outpatient clinic of the clinical pharmacology unit of the H Mondor-A Chenevier Hospital for ABPM performance from January 2007 to January 2012. The 2089 subjects included treated essential hypertensive patients assessed for treatment efficacy and untreated patients referred for confirmation of hypertension (based on elevated office BP). Exclusion criteria were secondary causes of hypertension, treatment for heart failure, chronic renal failure, and ABPM with Ͻ80% of valid measurements. Oral informed consent was obtained from each subject, and the study protocol was reviewed and approved by the institutional ethics committee (CPP Ile de France IX).
Ambulatory BP was recorded using a validated auscultatory device (Diasys Integra, Novacor, Rueil-Malmaison, France) set to take a reading every 15 minutes during the day and 30 minutes during the night. Short-term BPV was defined as in the learning population (see above). cfPWV was determined with the Complior system (Alam Medical, Vincennes, France), which uses simultaneous tonometry at the site of carotid and femoral arteries and determines PWV using direct carotid-to-femoral distance (tape meter) and transit time from second derivative algorithm. 40 
Statistical Analysis
Descriptive statistics are presented as meanϮSD. Continuous variables were tested to detect substantial deviations from normality by computing the Kolmogorov-Smirnov Z, and the assumption of satisfactory normal distribution was met for all of the examined variables. Pearson correlation coefficients were used to explore the bivariate associations between examined variables, and coefficients from the same sample were compared through the use of the Fisher r-to-z transformation. 41 Partial Pearson correlation coefficients (keeping age, sex, and 24-hour SBP or DBP constant) were used when appropriate.
Stepwise multiple linear regression models were constructed using important covariates from correlation analyses to elucidate independent determinants of cfPWV. In the regression models, group effect, age, sex, smoking habits (current versus past/never smokers), body mass index, office heart rate, fasting plasma glucose, estimated glomerular filtration rate, and office and 24-hour SBP were considered as explanatory variables of cfPWV, together with the following measures of SBP variability, which were added to the model one at a time: 24-hour conventional SD, day-SD, night-SD, wSD, and ARV. In multivariate models, P-to-enter was set at 0.10 and the P-to-stay to 0.05. Graphical inspection of scatter plots between predicted values of the dependent variable and regression standardized residuals excluded any heteroscedasticity of distribution. The final models were evaluated for other linear relationships among variables in the model (collinearity), which have the potential of rendering significance testing unreliable, including eigenvalues, variance inflation values, and condition indices. All fell within published guidelines, indicating no collinearity among the covariates in the models. 42 Given the possibility of a bidirectional relationship between BPV and cfPWV, we additionally analyzed a multivariate model in which ARV of 24-hour SBP was included as a dependent variable and, as independent variables, cfPWV, age, sex, smoking habits (current versus past/never smokers), body mass index, office heart rate, fasting plasma glucose, estimated glomerular filtration rate, and office and 24-hour SBPs. P levels Ͻ0.05 were considered statistically significant for all of the analyses.
Results

Learning Population
Of 949 untreated hypertensive patients, 911 (96%) had ABPM recordings of adequate technical quality and were included in the study. Clinical characteristics of the learning population are reported in Table 1 . Subjects in the IRIS group were slightly older and more frequently female. Office BP and fasting plasma glucose were higher, whereas average 24-hour SBP and DBP did not differ in the 2 groups. As shown in Table 2 , both office and 24-hour SBPs had a direct relationship with cfPWV. All of the measures of short-term SBP variability were consistently and directly related to cfPWV. ARV of 24-hour SBP had the strongest relation with cfPWV (rϭ0.26; PϽ0.001; Figure 1 ), followed by the wSD of 24-hour SBP and by the day-SD, 24-hour SD, and night-SD of SBP, in descending order of importance.
The above relations between cfPWV and SBP variability measures remained significant in a partial correlation analysis, which took into account the effects of age, sex, and 24-hour SBP (Table 2 ). After adjusting for the effect of age, sex, and 24-hour SBP (Figure 2, top) , the relation of cfPWV with the ARV of 24-hour SBP was significantly stronger than that with the SD of 24-hour, day, or night SBP (z statistics, Pϭ0.032, Pϭ0.051, and PϽ0.001, respectively) but did not differ from that with the weighted SD (Pϭ0.13). The relation of cfPWV with wSD was significantly stronger than that with the night-SD (PϽ0.001) but did not differ from those with 24-hours SD or day-SD (Pϭ0.34 and Pϭ0.18, respectively).
Within each quartile of 24-hour SBP, age-adjusted cfPWV was higher in the groups at high ARV as compared with those with low ARV (Figure 3) .
The relations of DBP and of its variability with aortic stiffness were generally weaker than those of SBP and its variability (Table 3) . Average 24-hour DBP had a weak direct relation with cfPWV. None of the examined measures of DBP variability had a significant relation with aortic stiffness.
The independent relations between BPV and cfPWV were examined in stepwise multivariate linear regression models. ARV of 24-hour SBP was independently associated with cfPWV along with 24-hour SBP, age, heart rate, estimated glomerular filtration rate, and fasting serum glucose (Table  4) . Smoking habits, body mass index, and serum cholesterol did not enter the final equation. As shown in Table S1 (available in the online-only Data Supplement), cfPWV had Given the cross-sectional nature of our data set, which does not allow us to interpret in a causal manner the link between BPV and cfPWV, we also examined the relationship between arterial stiffness and BPV by considering ARV as the dependent variable. In a multivariable model (Table S2) 
Test Population
Of 2304 hypertensive patients, 2089 (91%) had ABPM recordings of adequate technical quality and were included in the study. Clinical characteristics of the test population are reported in Table S3 . Average age was 56Ϯ13 years; 25% of the patients were diabetic, 41% were dyslipidemic, and 83% were receiving antihypertensive drug treatment with an average of 1.4 drugs (17% angiotensin-converting enzyme inhibitors, 29% angiotensin receptor blockers, 27% calciumchannel blockers, 26% diuretics, and 26% ␤-blockers). As shown in Table 2 , all of the measures of SBP variability were related to cfPWV, both before and after adjustment for age, sex, and office SBP. The relation of cfPWV with ARV Figure S1 (available in the onlineonly Data Supplement).
In the test population, conventional 24-hour, day, and night SDs of SBP had generally weaker relationships with cfPWV than ARV or wSD. In particular, the relation of cfPWV with ARV was stronger than that with 24-hour, day-, or night-SD of SBP (z statistics, Pϭ0.025, Pϭ0.014, and PϽ0.001, respectively). Similarly, the relation of cfPWV with wSD of 24-hour SBP was significantly stronger than with the SD of 24-hour, daytime, or nighttime SBP (z statistics, Pϭ0.04, PϽ0.001, and PϽ0.001, respectively) but did not differ from that with ARV of SBP (Pϭ0.38). Similar to the learning population, the relations of DBP variability with aortic stiffness were generally weaker than those of SBP variability ( Table 3 ). The independent relation between BPV and cf-PWV was confirmed in a stepwise multivariate linear regression model. ARV was independently related to cfPWV together with office SBP, age, diabetes mellitus, heart rate, and body mass index (Table 4) . 
Discussion
Our article offers unequivocal evidence of the occurrence of a significant relation between large-artery stiffness, as assessed by cfPWV, and different measures of systolic BPV over the 24 hours. This represents novel information for the first time obtained with proper methodology in a large group of hypertensive patients.
In this regard, our study has important merits. First, the demonstration that 24-hour variability of SBP, in particular when focusing on its short-term components, is related to cfPWV, was initially provided in a large "learning" population of 911 untreated patients with essential hypertension and was then confirmed in a larger "test" population of 2089 "real-life" patients, both treated and untreated, referred to a hypertension care center. Second, the demonstration of the link between BPV and cfPWV was provided by considering only 24-hour ambulatory BP recordings of high quality, which, in the learning population, were included in the analysis only after a careful quality check performed by experts in the field. This was done with the aim of excluding all "noisy" recordings in which either the limited number of measurements available or the frequency of artifacts might undermine the accuracy of BPV analysis. The same was true also for cfPWV assessment, all tonometric recordings having been accurately checked for quality by experts in the field before pulse wave analysis. Third, the link between short-term BPV and cfPWV was confirmed through multivariate analysis, showing that such a link is independent from, and in addition to, the relation between PWV with office and average 24-hour BP. 43 Other findings of our study deserve to be discussed. Among them is the evidence that the strength of the association between BPV and aortic stiffness may be sensitive to how BPV is defined. The closest association was found between cfPWV and ARV, that is, with an index of BPV that focuses on very short-term BP fluctuations between successive readings. Its sensitivity to short-term BP changes made this index superior to most of the various BP SDs considered in relation to aortic stiffness. Indeed, it allows us to differentiate between dynamic patterns of short-term BPV that cannot be identified by computing any of the BP SDs, which, in turn, quantify the distribution of BP readings around a mean value, not accounting for the order in which the BP measurements are obtained. 20 The next measure of BPV that best correlated with arterial stiffness, resulting not significantly different from ARV at statistical analysis, was the weighted 24-hour SD of SBP. This index 15 is based on the average of the SDs of daytime and nighttime BP values, separately quantified and "weighted" for the duration in hours of the day and night subperiods. The resulting 24-hour SD reflects BP fluctuations occurring during both daytime and nighttime but is free from any influence of day-night BP changes. Given that the degree of nocturnal fall in BP has favorable prognostic value, an index that might exclude the day-night BP fall from the quantification of overall 24-hour variance may, thus, better predict the adverse consequence of an increased short-term BPV, including an increased largeartery stiffness. Also day-to-day SBP variability, a parameter for which the prognostic relevance has been suggested recently, 44 might have an impact on cfPWV, 45 although it had a limited ability to maintain a predictive power in a multivariate model that included the major confounders of the association between cfPWV and BPV. 45 Overall, in the present study the independent contribution of BPV to aortic stiffness, although statistically significant and confirmed in 2 unrelated populations, was of limited size, thus emphasizing the importance of other factors in this regard.
In our article we also provide additional evidence that SBP variability and not DBP variability is associated with aortic stiffness. This is not surprising, if we consider that an increase in aortic stiffness was found associated with pulse pressure already many years ago. 46 Indeed, aortic stiffness together with stroke volume determines the amplitude of pulse pressure. In return, elevated BP leads to a passive increase in arterial stiffness through the recruitment of collagen fibers in the wall, which explains the disproportionate increase in SBP as compared with that of DBP.
An important question raised by our data concerns the mechanisms that might be responsible for the association between cfPWV and short-term BPV. First of all, given the cross-sectional nature of our study, we cannot conclude on the existence of any causal link between cfPWV and shortterm SBP variability. In other words, it might well be that an increase in aortic stiffness contributes to determine an increased short-term BPV, but it might also be that an increase in SBP variability determines an increase in cfPWV as a marker of the occurrence of organ damage at the level of large arteries. Both possibilities might be true, leading to a vicious circle. Animal data are available to support the second possibility. Sasaki et al 28 and Lacolley et al 29, 30 provided evidence that an increase in BPV induced by arterial baroreceptor denervation in rats, without an accompanying increase in mean BP levels, was associated with signs of aortic atherosclerosis, with a reduced arterial distensibility and with an increased collagen content and density in arterial walls. This issue would need to be addressed more in depth by longitudinal ad hoc studies in humans, exploring in a prospective manner the ability of an increase in BPV to predict the worsening of aortic stiffness or, on the contrary, the ability of a treatment-induced reduction in BPV to decrease arterial stiffness. Such studies, however, are currently impossible to perform in humans in the absence of drugs specifically decreasing BPV without changing BP mean levels.
It might well be, however, that also an increased arterial stiffness leads to a more pronounced BPV, these 2 parameters being associated in a closed loop manner. Also in this case, to test such a possibility in humans, interventions able to selectively reduce aortic stiffness without changing mean BP levels would be required, which are not currently available. 47 The favoring effect of aortic stiffness in determining an increased short-term BPV might be mediated by a reduced arterial baroreflex sensitivity, a rigid carotid and aortic wall being responsible for a reduced stimulation of arterial baroreceptors located in these vascular areas by pulsatile BP, with a consequent reduced sensitivity of the baroreflex and its resulting reduced efficacy in buffering BP fluctuations. 48, 49 Such a reduced baroreflex sensitivity, which is a characteristic feature of autonomic cardiac modulation in hypertension, might be one of the factors, together with the accompanying increase in arterial stiffness, responsible for the higher speed of changes in beat-to-beat SBP fluctuations reported to occur in hypertensive patients as compared with normotensive individuals. 50 Nothwithstanding the novelty of our results, we should acknowledge a few limitations of our study. First, the partial heterogeneity of the different populations was considered, in particular, in the learning and the test population. This heterogeneity, however, could even be seen as a positive feature of our study, insofar as it enhances the generalizability of our findings by extending them to real-life hypertensive populations. Second, BPV was higher in the test population than in the learning population, probably because of differences in demographic and clinical characteristics and the use of different ABPM devices in the 2 studies (SpaceLabs device in the learning population and Diasys Integra in the test population). Although both are validated in terms of individual measurements and, thus, expected to provide similar average BP values, no validation exists for BPV estimates so far. Different algorithms for artifact rejection and data editing implemented in different devices might lead to different BPV estimates. This should not affect the validity of the results, however, provided that the same device is used in all of the subjects in a given population, and no direct numeric comparisons are made between BPV estimates obtained with different devices. Third, the cross-sectional nature of our study, as underlined previously, did not allow us to clarify whether it is an increased BPV that determines an increased aortic stiffness or vice versa.
Perspectives
Our cross-sectional findings should pave the way for future longitudinal studies aimed at assessing how much an increased aortic stiffness might determine an increase in short-term BPV and, at the same time, how much an increased BPV might contribute to organ damage at the vascular level and, thus, to an increase in large artery stiffness. The relative contributions of an increased aortic stiffness and of an increased short-term BPV to cardiovascular complications of hypertension also need to be better understood. Our results raise a final issue, that is, how we might protect hypertensive patients from the combined negative effects of an increase in BPV and, at the same time, of an increase in aortic stiffness. Also in this case, intervention outcome studies are needed that might explore which treatments might be more effective in this regard.
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Novelty and Significance
What Is New?
• Not only office and average 24-hour BP but also short-term BPV is an independent predictor of aortic stiffness.
• The relation between BPV and aortic stiffness may be sensitive to the method chosen for assessing BPV.
What Is Relevant?
• An independent relation between BPV and aortic stiffness has been found in 2 large, unrelated populations of hypertensive patients.
Summary
In both treated and untreated hypertensive patients, short-term SBP variability over the 24 hours has a direct relationship with aortic stiffness, independent of the influence of age, average BP, and other variables. The relationship is stronger for measures of BPV focusing on short-term changes, such as average real variability and weighted SD of 24-hour SBP.
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